REgistry-based randomized controlled trial of treatment and Duration and mortality in long-term OXygen therapy (REDOX) study protocol
Version 3 2024-06-18, 13:45
Version 2 2024-06-04, 10:05
Version 1 2019-02-26, 00:00
journal contribution
posted on 2024-06-18, 13:45 authored by J Sundh, A Bornefalk-Hermansson, Z Ahmadi, A Blomberg, C Janson, DC Currow, CF McDonald, Nikki McCaffreyNikki McCaffrey, M EkströmREgistry-based randomized controlled trial of treatment and Duration and mortality in long-term OXygen therapy (REDOX) study protocol
History
Related Materials
- 1.
Location
EnglandOpen access
- Yes
Language
EnglishPublication classification
C1 Refereed article in a scholarly journalCopyright notice
2019, The Author(s)Journal
BMC Pulmonary MedicineVolume
19Article number
ARTN 50Pagination
1 - 8ISSN
1471-2466eISSN
1471-2466Issue
1Publisher
BMCUsage metrics
Keywords
Science & TechnologyLife Sciences & BiomedicineRespiratory SystemRegister-based randomized controlled trialHypoxaemiaLong-term oxygen therapyOxygen durationChronic obstructive pulmonary diseaseInterstitial lung diseaseMortalityHospitalizationsHealth-related quality of lifeSymptomsOBSTRUCTIVE PULMONARY-DISEASECOGNITIVE DECLINEOXIDATIVE STRESSDYSPNEACOPDEXPERIENCE3201 Cardiovascular medicine and haematology4202 Epidemiology
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC